Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 4
2022 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
[Controlled asystole donation in the paediatric patient].
Butragueño Laiseca L, Sancho González M, López-Herce Cid J, Mencía Bartolomé S. Butragueño Laiseca L, et al. Among authors: sancho gonzalez m. An Pediatr (Engl Ed). 2020 May;92(5):299-300. doi: 10.1016/j.anpedi.2019.06.006. Epub 2019 Jul 21. An Pediatr (Engl Ed). 2020. PMID: 31340897 Free article. Spanish. No abstract available.
Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients.
Balandín B, Pintado V, Pérez-Pedrero MJ, Martínez-Sagasti F, Sancho-González M, Soriano-Cuesta C, Gesso CM, Chicot M, de Luna RR, Asensio-Martín MJ, Catalan M, Díaz-Díaz JJ, Carbonell N, Iranzo R, Royuela A, Ballesteros D. Balandín B, et al. Among authors: sancho gonzalez m. Int J Antimicrob Agents. 2024 May;63(5):107121. doi: 10.1016/j.ijantimicag.2024.107121. Epub 2024 Feb 24. Int J Antimicrob Agents. 2024. PMID: 38408494 No abstract available.
Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients.
Balandín B, Ballesteros D, Pintado V, Soriano-Cuesta C, Cid-Tovar I, Sancho-González M, Pérez-Pedrero MJ, Chicot M, Asensio-Martín MJ, Silva JA, de Luna RR, Gesso CM, Rodríguez-Serrano DA, Martínez-Sagasti F, Royuela A. Balandín B, et al. Among authors: sancho gonzalez m. Int J Antimicrob Agents. 2022 Mar;59(3):106536. doi: 10.1016/j.ijantimicag.2022.106536. Epub 2022 Jan 25. Int J Antimicrob Agents. 2022. PMID: 35091054
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Rodriguez-Gonzalez CG, Chamorro-de-Vega E, Valerio M, Amor-Garcia MA, Tejerina F, Sancho-Gonzalez M, Narrillos-Moraza A, Gimenez-Manzorro A, Manrique-Rodriguez S, Machado M, Olmedo M, Escudero-Vilaplana V, Villanueva-Bueno C, Torroba-Sanz B, Melgarejo-Ortuño A, Vicente-Valor J, Herranz A, Bouza E, Muñoz P, Sanjurjo M. Rodriguez-Gonzalez CG, et al. Among authors: sancho gonzalez m. Int J Antimicrob Agents. 2021 Feb;57(2):106249. doi: 10.1016/j.ijantimicag.2020.106249. Epub 2020 Nov 28. Int J Antimicrob Agents. 2021. PMID: 33259918 Free PMC article.
Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
Balandin B, Ballesteros D, Ruiz de Luna R, López-Vergara L, Pintado V, Sancho-González M, Soriano-Cuesta C, Pérez-Pedrero MJ, Asensio-Martín MJ, Fernández-Simón I, Rodríguez-Serrano D, Silva A, Chicot M, Iranzo R, Martínez-Sagasti F, Royuela A. Balandin B, et al. Among authors: sancho gonzalez m. Int J Antimicrob Agents. 2021 Mar;57(3):106270. doi: 10.1016/j.ijantimicag.2020.106270. Epub 2021 Jan 19. Int J Antimicrob Agents. 2021. PMID: 33347991
Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study.
Oblitas CM, Galeano-Valle F, Ramírez-Navarro J, López-Cano J, Monterrubio-Manrique Á, García-Gámiz M, Sancho-González M, Arenal-López S, Álvarez-Sala Walther LA, Demelo-Rodríguez P. Oblitas CM, et al. Among authors: sancho gonzalez m. Viruses. 2021 Dec 6;13(12):2445. doi: 10.3390/v13122445. Viruses. 2021. PMID: 34960714 Free PMC article.
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
Chamorro-de-Vega E, Rodriguez-Gonzalez CG, Manrique-Rodríguez S, Lobato-Matilla E, García-Moreno F, Olmedo M, Correa-Rocha R, Valerio M, Aldámiz-Echevarria T, Machado M, Sancho-Gonzalez M, Lopez-Bernaldo-de-Quirós JC, Ruiz-Briones P, Romero-Jiménez R, Sarobe-González C, Gimenez-Manzorro A, Collado-Borrell R, Fernandez-Llamazares CM, Revuelta-Herrero JL, Somoza-Fernandez B, Garcia-Sanchez S, Taladriz-Sender I, Bouza E, Herranz A, Muñoz P, Sanjurjo M. Chamorro-de-Vega E, et al. Among authors: sancho gonzalez m. Expert Rev Clin Pharmacol. 2021 Feb;14(2):249-260. doi: 10.1080/17512433.2021.1875819. Epub 2021 Jan 26. Expert Rev Clin Pharmacol. 2021. PMID: 33499687 Free PMC article.